Skip to main content
FSNUY logo

FSNUY · Fresenius SE & Co. KGaA

$12.63 +0.30 (+2.43%) At close · Jul 21
Market Cap
$28.45B
Shares
2.25B

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$12.63 Open$12.38 Day$12.38–12.85 52W$10.33–33.93 Avg vol 30d219K Short int282K · 0.0% float · 1.0d Short vol34% DataJan 2020–Jul 2026

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Weak Sentiment Bearish Fundamentals Limited Quant / Vol High
Market backdrop VIX 18.7 · elevated Equity put/call 0.66
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −6%
below
Price vs 50-day avg +10%
above
RSI (14) 67
neutral
MACD trend Positive
52-week position 10%
near low
Momentum
relative strength
Weak
1-month return +12%
trailing
6-month return −15%
trailing
YTD return −12%
this year
Relative strength −23%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $11 › 200d $13 — 200d above 50d
Institutional flow Distributing
2 of 5 funds reported for Jun 30 · net -26.0K sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.01% of float · ▲ +375.6% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
5 holders — mid 3-yr range
Squeeze score 45
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
High
Volatility 39%
annualized · 1-yr
Max drawdown −54%
past year
ATR 2.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
2 · 2 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−6% Bearish
Price vs 50-day avg
+10% Bullish
RSI (14)
67 Neutral
MACD trend
Positive Bullish
52-week position
10% Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $11 › 200d $13 — 200d above 50d
Institutional flow Distributing
2 of 5 funds reported for Jun 30 · net -26.0K sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.01% of float · ▲ +375.6% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
5 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $10 Now $13 · 10% 52-wk high $34
vs 200-day avg -6% vs 50-day avg +10%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Care Facilities — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
FSNUY
Fresenius SE & Co. KGaA
this stock
$28.45B -11.9% 0.0%
HCA
HCA Healthcare, Inc.
$82.77B -20.0% +7.1% 12.9 2.4%
THC
Tenet Healthcare Corp
$16.93B -1.1% -2.3% 10.2 4.3%
DVA
Davita Inc.
$15.23B +108.9% +6.5% 22.2 7.1%
FMS
Fresenius Medical Care AG
$13.26B +3.6% 0.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
4
% held
0.0%
Reported
2 of 5
Top holder
RHUMBLINE ADVISERS
Held Float
View
Held by Funds
Fund positions
2
View
Short & Settlement
Short Interest Rising
Shares short
282.0K
Days to cover
1.0d
Change
+222.7K sh
View
Short Volume
Short vol %
34%
As of
Jul 21, 2026
Short Total
View
Fails to Deliver
FTD shares
114.5K
Value
$1.3M
As of
Jun 30, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
May 4, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Buy
Member
Alan Armstrong
Amount
$1.0K–$15.0K
Traded
Mar 30, 2026
View
Earnings & Events
Investor Relations
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
FSNUY +7.6% +11.8% -15.2% +10.5% -11.9%
SPY -0.5% +0.5% +7.6% +0.2% +9.7%
vs SPY +8.1% +11.3% -22.8% +10.3% -21.6%

Capital returns

Latest dividend
$0.307 / share · ex May 26, 2026
Raised 8.5%
Paid (TTM)
$0.307 / share · 1 payout
Dividend yield (TTM, derived)
· history filling in

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 904868 CUSIP 35804M105 13F (30d) 1 filings 1 filers Visit website Investor relations